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(CNB-A)Protein kinase Ia (PKGIa) is a pivotal cyclic guanosine monophosphate (cGMP) signalling protein. Major
steps related to the structural plasticity of PKGIa have been inferred but the structural aspects of the
auto-inhibition and multidomain tertiary organization of human PKGIa in active and inactive form are
not clear. Here we combine computational comparative modelling, protein–protein docking and molec-
ular dynamics (MD) simulations to investigate structural details of the repressed state of the catalytic
domain of PKGIa. Exploration of the potential inhibitory conformation of the auto-inhibitory domain
(AI) within the catalytic cleft reveals that the pseudo-substrate motif binds with residues of the glycine
rich loop and substrate-binding lobe. Dynamic changes as a result of coupling of the catalytic and AI
domains are also investigated. The three-dimensional homodimeric models of PKGIa in the active and
inactive state indicate that PKGIa in its inactive-state attains a compact globular structure where cyclic
nucleotide binding (CNB-A/B) domains are buried, whereas the catalytic domains are inaccessible with
their substrate-binding pockets facing the N-terminal of CNB-A. Contrary to this, the active-state model
of PKGIa shows an extended conformation where CNB-A/B domains are slightly rearranged and the cat-
alytic domains of homodimer flanking the C-terminal with their substrate binding lobes free to entrap
downstream proteins. These findings are consistent with previously reported static images of the mul-
tidomain organization of PKGIa. Structural insights pertaining to the conformational heterogeneity and
auto-inhibition of PKGIa provided in this study may help to understand the dynamics-driven effective
regulation of PKGIa.
 2020 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Bio-
technology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Background
Cyclic guanosine monophosphate (cGMP) specific protein
kinase (PKG), a core regulator of the cGMP signalling pathway, dis-
plays a kinase-specific conformational heterogeneity at the struc-
tural level. In mammals, PKG has three isoforms, namely PKGIa,
PKGIb and PKGII, which share an almost identical domain configu-
ration [1,2]. Like other eukaryotic kinases, cGMP specific protein
kinases (PKGs) behave as dynamic switches; they exist in a com-pact ball-like folded form in their native cGMP-free inactive func-
tional state but adopt a strikingly different and distinct cGMP-
dependent extended conformation in the active functional state
[2,3]. The consequences of cGMP binding to PKGI at a structural
level have been a focus of investigation for more than 40 years
and much is now understood at the single- or double-domain level.
However, the quest to solve the structures of the full-length, mul-
tidomain structural assemblies of the two key functional states (in-
hibited and catalytically active) of human PKGs is still in progress
[4,5].
Each PKG polypeptide is divided into two regions: a regulatory
(R) region and a catalytic (C) region. The regulatory region is com-
posed of four functional domains [1]. At the N-terminus, a coiled-
coil leucine zipper is present, which is important for the homod-
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leucine zipper domain is an auto-inhibitory (AI) domain, which
engages the catalytic region of the PKG in the committed/inactive
state. Next to the AI domain, there are two tandemly arranged low
and high affinity cGMP binding domains (CNB-A & CNB-B) [2]. The
C-terminal catalytic region of PKG, depicted in Fig. 1A, is further
subdivided into two sub-domains: the kinase sub-domain where
the Mg2+/ATP binds and the AGC-kinase C-terminal domain where
substrate/downstream proteins bind and phosphorylation occurs
[6].
High-resolution protein structures determined by X-ray crystal-
lography and NMR techniques have provided a wealth of structural
information on the isolated domains of PKGIa and PKGIb. Crystal
structures of the individual leucine zipper domain (PDB Id: 4R4L)
and cyclic nucleotide-binding domains (CNB-A and CNB-B) (PDB
Id: 4Z07) in the dimeric state have revealed the molecular details
of the cGMP-dependent conformational change leading to the acti-
vation and dimerization of PKGIa. In addition to this, the catalytic
domain has been solved in both the apo-form (PDB Id: 6BDL) and
the ligand-bound form (PDB Id: 6C0T) [7,8], but the structural basis
of the auto-inhibitory mechanism in PKGIa is still obscure and
needs to be addressed as part of understanding the structural
assembly of the inactive human PKGIa.
cGMP protein kinases including PKGIa, PKGIb and PKGII possess
an AI domain at the N-terminal regulatory region that carries an
inhibitory motif called the ‘‘pseudo-substrate” motif to regulate
the activation of catalytic domain [10,11]. Consistent with the
highly conserved function of the auto-inhibitory mechanism pre-
sent in eukaryotic protein kinases, previous studies have identified
conserved residues of the substrate-like motif of the AI domain
[12–15]. However, how the AI domain engages the catalytic cleft
in the inactive state is not understood. Which residues and what
kind of molecular interactions stabilize the inhibited state of the
catalytic domain need further investigation, as do the existence
of any conformational changes within the catalytic domain to
accommodate the AI domain. In this investigation, we focus on
the study of the conformation of the AI domain with the potential
to inhibit the activity of human PKGIa when complexed with the
catalytic domain.
The proteins central to the human cGMP signalling pathway are
complex, large multi-domains structures. Despite the improve-
ment in experimental methods of protein structure determination,
there are still limitations in defining the assembly of human multi-
domain protein complexes [16]. Recent studies have explored how
to leverage and integrate the computational structure-prediction
techniques with already known experimental data of the protein
fragments for the holistic determination of the quaternary struc-
tures and dynamics of human multi-domain proteins [17–19].
In the case of PKGIa, hypothetical models of inactive and active
conformations of human PKGIa have been proposed based on the
aforementioned structural data of standalone domains of PKGIb
and closely related homologous structures of cyclic adenosine
monophosphate kinase (PKA) [9,20]. The inactive and active state
models given in Fig. 1B portray the relative orientations of adjacent
domains that govern the quaternary packing of PKGI homodimer in
both functional states [9]. These models serve nicely as the starting
point for computational assembly and prediction of a comprehen-
sive multicomponent structure of PKGI-a in catalytically commit-
ted (active) as well as uncommitted (inactive) states.
To model the inactive PKGIa, it is crucial to understand the
structural details of the association of AI and catalytic domains
while in the inactive state. The lack of availability of the structure
of the AI domain and its low (<20%) sequence identity with other
known proteins make it extremely challenging to delineate the
functional relationship of the AI domain to the auto-inhibitory
mechanism of PKGIa.In the present study, we explore the spatial orientation/ binding
mode of the AI domain within the PKGIa catalytic domain as well
as the nature of the molecular interactions between the AI-
catalytic domain complex using a protein-structure modelling
approach coupled with protein–protein docking and molecular
dynamics (MD) simulations. In the first step, the three dimensional
(3D) computational protein model was predicted and then docked
into the catalytic domain to probe the near-native repressed state
of the PKGIa catalytic domain. Multiple docked conformations of
the AI-catalytic domain complex were evaluated through MD sim-
ulations to map out the approximate binding mode and resultant
conformational transitions of the restrained state of the catalytic
domain that occur in response to the binding of AI domain inside
the catalytic cleft.
The present study was further extended to the full-length struc-
ture prediction of the PKGIa in both key states to map the confor-
mational diversity of PKGIa in the cGMP signalling pathway.2. Materials and methods
2.1. Structure prediction of auto-inhibitory subdomain through
threading
Determining the structure of the AI domain is the cornerstone
to understanding the molecular organisation, autoinhibitory mech-
anism and activation of the full length PKGIa. In PKGIa, there is no
experimentally solved structure for the region spanning amino
acids 47 to 102. This sequence region covering 25 functionally
important amino acids of the AI domain binds and inactivates
the catalytic region through the pseudo-substrate motif, to down-
regulate the activity of PKGIa. To define the structure of the AI
domain, the amino acid sequence of the query structure was
retrieved from UniProt (Uniprot ID: Q13976) [21] and a PSI-
BLAST search was performed against the Protein Data Bank (PDB)
templates [22,23]. All the templates identified in the BLAST search
were < 20% in sequence identity to the query sequence. In the
absence of an appropriate template, a threading technique was
employed for 3D structure prediction. The AI domain accounts
for 25 residues which was too short for the structure prediction
on I-TASSER suite [24] hence, the sequence length was extended
to 55 amino acids. This was done to reduce false positivity in the
results and achieve a good quality model. I-TASSER identified the
10 best templates by using LOMETs and generated multiple tem-
plate sequence alignments using a number of threading programs.
The initial model was selected based on TMalign [25] and C-score
[26]. Model refinement was performed in UCSF Chimera [27] and
evaluation of the refined model was achieved using RAMPAGE
and MolProbity [28].
2.2. Protein–protein docking of catalytic & auto-inhibitory domain
Past studies reported that the N-terminal AI domain takes hold
of the C-terminal catalytic domain in the PKGIa inactive state.
Interaction of the two oppositely located domains induces a com-
pact ball-like folded state. There is no homologous template avail-
able to aid in the prediction of the proposed inhibited/ committed
conformation of the catalytic and AI domains. To investigate the
correct orientation as well as the role of the AI domain in the
repressed state of PKGIa, a predicted model of the AI domain
was docked inside the active cleft of the catalytic pocket (PDB
Id:6C0T) [7] using three different protein–protein docking pro-
grams, i.e. DOCK module of ClusPro [29], GRAMMX server [30]
and pyDock [31]. A few biochemical studies report the composition
of the pseudo-substrate motif of the AI domain based on the evo-
lutionary conservation with its closely related homologous region
Fig. 1. A) The domain architecture of PKGIa. PKGIa is divided into regulatory and catalytic regions. The regulatory region comprises a leucine zipper domain (grey), auto-
inhibitory domain (AI) (magenta), cGMP high affinity binding domain (purple) and cGMP low affinity binding domain (cyan). At the C-terminus, the catalytic domain is
present and highlighted in green colour. Domain boundaries and PDB IDs of structurally solved domains are given below. Phosphorylation and acetylation sites of the
respective domains are also highlighted. B) Models illustrating how human PKGIa folds in its inactive and active conformations (9). (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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pyDock and ClusPro, restraints describing known residues of the AI
domain were defined for their preferential docking within the cat-
alytic cleft. At first multiple top ranked docked complexes were
subjected to two-dimensional (2D) interaction analysis using Lig-
plot+ to screen the best docked poses with potential interactions
between catalytic domain residues and already known pseudo-
substrate residues of the AI domain. These complexes were then
further selected for three-dimensional (3D) interaction analysis
where four out of the six residues of the pseudo-substrate motif
(RAQGISA) were interacting with the catalytic domain. Shape com-
plementarity according to the proposed inactive conformation was
also an additional criterion for the selection of potential docked
poses. A comprehensive three-dimensional (3D) interaction analy-
sis was performed in Intermezzo (Ochoa Montano B, Blundell TL,
unpublished) to confirm the nature of intermolecular interactions
in our selected docked complexes. The Intermezzo generated inter-
action analysis was refined in PyMol [34]. To investigate the poten-
tial binding pocket and/or catalytic residues of the PKGIa catalytic
domain, hotspot analysis and ligand-interaction analysis of the co-
crystal structure of PKGIa catalytic domain (PDB Id: 6C0T) were
also performed using the Fragment Hotspots web application
[35] and Ligplot+ tool. These analyses helped us to identify the cat-
alytic residues and active site groove of the catalytic domain so
that the occupancy of secondary structural elements of the cat-
alytic pocket by the residues of the AI domain can be observed.
Docking energy, inhibitory conformation and maximum number
of inter-domain molecular interactions were used to choose three
best complexes.2.3. Molecular dynamics simulations
Of the three top ranked structures, AI2 and AI3 were selected for
molecular dynamics (MD) simulations due to the higher number of
hydrogen-bond interactions and occupancy of phosphorylation
sites in the inhibited state. All atom MD simulations were per-formed through Amber14 [36]. The apo-form of the catalytic
domain of PKGIa (PDB Id: 6BDL) was also used for MD simulations.
The correct protonation states of the ionizable amino acids in our
selected complexes were identified through UCSF Chimera
PDB2PQR tool [27] using the AMBER (ff14SB) force-field [37]. Sol-
vation of all the protein complexes under study was achieved using
a rectangular box of TIP3P water molecules [38]. TIP3P water was
extended 12 Å from solute atoms in all dimensions afterwards, and
systems were neutralized using sodium (Na+) and chloride (Cl-)
ions. All receptor structures were parameterized using AMBER
FF99SB force field [37].
Long-range electrostatics with a cutoff of 10 Å were computed
using the particle mesh Ewald (PME) method [39] and the same
cutoff was applied to detect the van der Waals interactions. Ini-
tially, the systems were minimized for 10,000 steps. During the
subsequent annealing, the Langevin thermostat was operated to
control the temperature from 0 to 300 K at constant volume
(NVT) for 200 ps. The SHAKE algorithm was employed to constrain
all bonds involving hydrogen atoms [40]. For all systems, 50 ns
simulation was executed at 300 K and 1 atm constant pressure
(NPT). Trajectory snapshots were obtained every 2 fs.2.3.1. Stability analysis of the auto-inhibitory catalytic-domain
complex
Post simulation processing of all the trajectories of the afore-
mentioned complexes was performed by employing the CPPTRAJ
v17.00 module [41]. Basic root-mean-square deviation (RMSD),
root-mean-square fluctuation (RMSF) and radius-of-gyration
(Rog) analysis were calculated to evaluate the stability of the sys-
tems throughout the simulation. RMSD analysis was estimated
for all backbone atoms of the complexes in which the starting
structure was taken as a reference frame. Similarly, the residual
fluctuation of backbone atoms was also calculated with RMSF anal-
ysis. In parallel, to evaluate whether the systems are steadily
folded or not throughout the assigned simulations time, the radius
of gyration (Rog) was also estimated for the selected complexes.
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the study were generated using Xmgrace [42].2.3.2. Hydrogen-bond analysis
In order to understand the role of hydrogen-bonding in the fold-
ing of the inactive state of PKGIa, we analysed the occurrence of
hydrogen-bonds between the AI domain and catalytic domain.
Domain-domain as well as intra-domain interactions were also
compared. Additionally, we compared the intra-domain
hydrogen-bond analysis of auto-inhibitory bound PKGIa com-
plexes with the apo-state of the catalytic domain to see the change
of the hydrogen-bonding pattern between the auto-inhibitory
bound and unbound states of the catalytic domain of PKGIa. We
anticipate that there would be a few promising movements in
the catalytic pocket of the PKGIa which help the AI domain to
adjust with in the catalytic domain for blocking its activity. To that
objective, MD trajectories of all complexes were subjected to
CPPTRAJ module [41] to obtain a comprehensive hydrogen-bond
analysis of AI2 and AI3 to explain different dynamic events attrib-
uted to hydrogen-bond occupancy.2.3.3. Essential dynamics
Principal Component Analysis (PCA) [43] was also performed to
understand the significant internal correlated structural transitions
that take place within the catalytic domain to accommodate the AI
domain. By utilizing MD trajectory data of AI2 and AI3, we identi-
fied and distinguished the secondary structure movement taking
place within the AI domain-bound catalytic structures as com-
pared to the apo-states. PCA uses structural transitions of the
backbone-atoms matrix by removing overall rotational and trans-
lational movements to construct a covariance matrix [44]. Struc-
turally uncorrelated variables known as 3 N eigenvectors
(eigenvalues) are extracted from the diagonalization of the covari-
ance matrix. Molecular dynamics simulation trajectories were then
projected over these eigenvectors so defining the modes and
amplitudes of the collective motions. These eigenvectors were cal-
culated in descending order where the first principal component
(PC-1) corresponds to the highest configurational space of the
macromolecule. Eigenvectors of the two AI domain bound com-
plexes and apo-system of PKGIa complexes were measured by
applying CPPTRAJ. Close examination demonstrated that the first
two eigenvalues constitute almost 80% of overall configurational
space. Visual Molecular Dynamics (VMD) and Normal Mode
Wizard (NMWiz) tools were employed to comprehensively investi-
gate the uncorrelated system transitions and create porcupine
plots respectively [45]. For graphical representations, PyMol and
VMD were used [46,47].2.4. Computational modelling of inactive and active state of PKGIa
Modelling of a multi-domain proteins where all the domains
are placed in correct relative orientations is one of the challenging
tasks of structural biology. Protein kinases are known to switch
between two opposite conformations corresponding to the inactive
and active states. Three-dimensional structural information of
PKGIa, including the conformational heterogeneity at the struc-
tural level of these two states, is crucial to understand the regula-
tion of cGMP signalling pathway. To that aim, we assembled
already available structural data to define their native quaternary
organization using a computational protein modelling and docking
approach. Kim et al., 2016 [9] provided a hypothesized pictorial
representation of putative quaternary packaging of the multi-
domain structure of full-length PKGI in both active and inactive
conformations; this has been used as a guide in the current study.2.4.1. Inactive state homology modelling
Efforts to obtain a complete atomic structure of PKGI in any of
the reported conformations have not yet been productive. Bakkouri
et al., 2019 have recently reported experimentally solved crystal
structures of PKG from Plasmodium falciparum and Plasmodium
vivax in their inactive conformations [48]. Although there has been
a pronounced divergence between Plasmodium and human cGMP
kinase, it was the only available structural information demon-
strating the folding behaviour of the tandem cGMP binding
domains and C-terminal catalytic domain in PKG. To understand
the tertiary architecture of inactive PKGIa, we applied comparative
modelling using Modeller v 9.20 [49]. The amino acid sequence of
PKGIa (UniProt ID: Q13976) was retrieved from UniProt and PSI-
BLAST was performed against all the known structures in the pro-
tein databank (PDB). An appropriate template with reasonable per-
centage identity in maximum query coverage was selected. It was
observed that the template structure is monomeric while literature
reports that the human PKGIa exists in the homodimeric state.
Crystal structures of leucine zipper domain (PDB Id: 4RL4) [50]
and tandem cGMP binding domains (CNB-A and CNB-B) (PDB Id:
4Z07) [9] have clearly defined the residues responsible for the
dimerization of PKGIa. Furthermore, domain orientation of the
template was also compared with the orientation of inactive-
state model of human PKGIa proposed by Kim et al., 2016. Only
half of the structure was kept as template in which individual
homologous domains are present in similar orientations to those
proposed in the aforementioned study. Sequence-structure homol-
ogy of template and query protein was also generated using Fugue
[51], which identifies distant homologues and provides sequence-
structure correlations of query proteins with known/solved homol-
ogous. It also provides 3D structural features of the protein
sequence in a structure alignment. Modeller [9.22] was then used
to build a single chain model [52]. The entire structure was used as
a template primarily to ensure similar domain orientation while
the local secondary structures of individual domains were kept
intact by using solved structures of human PKGIb CNB-A domain
(PDB Id: 3OGJ_C) in apo-form, CNB-B domain (PDB Id: 4Z07) and
catalytic domain (PDB Id: 6BDL) in apo-form as additional tem-
plates for modelling. Initially, the best model was selected based
on DOPE score [53] and GA341 values [54]. Sister chains were sub-
mitted to ClusPro server for protein–protein docking and the best
model was selected from all the clustered docked poses based on
a similar inactive conformation to that proposed in the literature.
2.4.2. Active state homology modelling
To build an active-state model model of human PKGIa, AIDA
(ab initio Domain Assembly) server [55] was used to assemble all
the individually known and predicted domains together in a single
chain. AIDA takes Protein Data Bank (PDB) files of individual
domains as well as the amino acid sequence of the query protein
to assemble all the consecutive domains. It uses PSI-Blast against
the PDB to calculate position specific scoring matrix (PSSM) which
was further employed to PSIPRED for calculating secondary struc-
tures and solvent accessibility. Based on the solvent accessibility
analysis it keeps the predicted buried residues inside the core
while the position of the domain which has high content of solvent
assessable residues lies on the periphery to interact with the adja-
cent domain. Continuous domains are then assembled through a
four-residue linker to attain a near native folded state. It returns
the final assembled model at a lower/stable energy state through
a built-in energy minimization protocol of AIDA. A full length
assembled PKGIa subunit was selected based on its smaller RMSD
value with the co-crystal structure of the tandem CNB (CNB-A/B)
domains of human PKG I beta with cGMP (4Z07). As we lacked
an entire length homologous template in dimeric form for our
query protein, we applied protein–protein docking to decipher
Fig. 2. Predicted model of AI domain of PKGIa.
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the AIDA predicted chains were submitted to DOCK module for
protein–protein docking in ClusPro server [29]. From the advanced
options, the multimeric docking option was applied with known
distance restraints based on experimentally-known structures to
get the best approximate homo-dimeric structure. The best docked
dimeric model was them compared with CNB-A/B dimeric crystal
structures to minimize the chance of predicting incorrect inter-
chain interactions in the folded state.
Energy minimizations of both inactive and active models were
performed in Schrödinger Release 2018 (Schrödinger Release
2018_4, LLC, New York, NY, 2018) by applying optimized potential
for liquid simulations 2005 (OPLS 2005) force field [56]. The quality
of the initial and refined inactive and active-state PKGIa models
was estimated using RAMPAGE [57]. Maestro 11.8 (Schrödinger
Release 2018-4: Maestro, Schrödinger, LLC, New York, NY, 2018)
was used for surface and cartoon figure illustration.3. Results
3.1. Homology modelling of the AI domain
From the top five predicted models, the best was selected based
on TM and RMSD scores. The functionally important pseudo-
substrate motif appears in the loop region and a long a-helix
was observed in all the predicted models. It was anticipated that
this N-terminal pseudo-substrate-motif-bearing region of the AI
domain will be highly flexible, so allowing the substrate-like motif
to engage with the catalytic domain. (shown in Fig. 2). The C-score
indicates the significance of threading-template alignments and
predicts a model based on the biological assembly of multiple sub-
structures. Typically its score lies between 5 and 2. C-score of our
predicted model of AI domain was 2.27 and TM score of
0.45 ± 0.14 Afterwards, the initial predicted model was further
refined to adjust overall geometry and stereo-chemical clashes
through energy minimization using MMF94s force field in UCSF
Chimera [27,58].3.2. Docking analysis of PKGIa auto-inhibitory domain & catalytic
domain
Based on the different orientations of the docked AI domain
within the PKGIa catalytic domain, our first docked conformer
was denoted as AI1, the second as AI2 and the third as AI3. Initially
a two-dimensional (2D) interaction analysis of these aforemen-
tioned docked poses was performed using Ligplot+ while a compre-
hensive three-dimensional (3D) interaction analysis elaborating all
the intermolecular interactions, i.e. hydrogen-bond interactions,
electrostatic interactions, van der Waals forces and hydrophobic
interactions that stabilize the affinity of the AI domain to catalytic
domain was done in Intermezzo. Ligplot+ results of three selected
docked complexes are given in supplementary Fig. 1.
Docking analysis of the AI1 complex revealed a dock score of
870.1 kcal/mol while the AI domain was observed to engage
the entry site of the catalytic pocket. In AI1 it was noted that the
highly flexible N-terminal loop containing the pseudo-substrate
motif is placed alongside where it is interacting more with the sur-
face residues (Fig. 3a). Multiple hydrogen-bonds, polar interac-
tions, ionic bonds and aromatic ring-ring interactions were
observed between the residues of AI domain and catalytic pocket
residues. Amongst the catalytic pocket residues, side chain atoms
of H396, E523 and F371 were participating in hydrogen-bonding
with the side chain atoms of S65, Q62 and Q79 respectively, while
T400, Q402, E488, G520 and D657 were making polar interactions
with the A66, P68, K83, Q79 and A61, respectively. In addition tothese interactions, ionic-bond formation between R401 of the cat-
alytic domain and E67 of the AI domain shown in Fig. 3d. Various
p-p stacking interactions were also observed between catalytic
domain residues, i.e. F505, W447, E488 and AI domain residues
i.e. Y71, F74, L77 and R82. The orientation of AI domain in AI1 com-
plex seems to interfere with the opening of the catalytic domain. In
the AI1 complex, five residues, A61, Q62, I64, S65 and A66, of the
seven residues of the pseudo-substrate motif (RAQGISA), were
involved in various electrostatic interactions with the surface resi-
dues catalytic domain. The smallest number of hydrogen-bonds
were observed in this complex.
Electrostatic interaction analysis of the AI2 complex revealed a
dense network of interdomain interactions that mediate the bind-
ing of the AI domain within the catalytic cleft of PKGIa. In our sec-
ond potent complex, the small helix was a little displaced from the
active pocket while ClusPro dock score was 960.0 kcal/mol
(Fig. 3b). In this complex, a small displacement of the AI domain’s
helix makes more room for the loop/unstructured part of the AI
domain containing pseudo-substrate motif (RAQGISA) to interfere
with the residues of the catalytic groove of the catalytic domain.
Three-dimensional molecular interaction analysis using Inter-
mezzo revealed fourteen hydrogen-bonds, eight van der Waals
interactions, three polar interactions and seven hydrophobic and/
or aromatic ring-ring interactions implicated in auto inhibition of
the catalytic region of PKGIa. Residues of AI domain such as R60,
A61, Q62, G63, I64, S65, A66, T70, Y71, R72, H75, L77 and F81 were
making hydrogen-bonds of different strengths with D657, E658,
N656, G369, G370, H396, E488, V368, R451, D650 and W447 of
the catalytic residues. In the AI2 complex, all significant pseudo-
substrate residues were participating through hydrogen-bonding
with the catalytic domain. Furthermore, eight van der Waals inter-
actions between R60, Q62, R78, Q79 and R82 residues of the AI
domain and N655, D657, K393, G370, R451, D650 and S651 of
the catalytic domain were fostering vital inter-domain contacts.
In addition to these, polar interactions between Y71, P68 and S65
were also established with G370 and E445 of the catalytic region.
Four hydrophobic interactions between catalytic residues i.e.
F652, V638, R371, D657 and AI domain residues, i.e. F74 and
Q62, were also evident in stabilizing the structural domain–do-
main interaction between PKGIa catalytic domain and AI domain
(Fig, 3e). None of the critical catalytic residues was found interact-
ing with the AI domain in the AI2 complex.
AI3, the third top ranked complex with plausible and/or poten-
tial inhibitory conformation with dock energy of 1666.0 kcal/mol,
was further explored through interaction analysis tools (Fig. 3c).
The highest number of hydrogen-bonds occurred in this docked
complex as compared to the AI1 and AI2 complex. Catalytic
Fig. 3. Surface representation of three different docked conformations (AI1, AI2, AI3) (a, b, c) of N-terminal AI domain (purple) into the C-terminal catalytic domain (green) of
PKGIa. (d, e, f) illustrate interaction diagrams of three conformers AI1, AI2, and AI3. Residues of the catalytic domain are labelled in blue and AI domain in black. Hydrogen-
bonds are highlighted in red, polar interactions in orange, ionic bonds in brown, van der Waals interactions in grey, hydrophobic interactions in blue, carbonyl interactions in
yellow and aromatic interactions in cyan. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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are interacting with the R60, Q62, G63, I64, S65, A66 (RAQGISA),
Y71, R78 motif by making hydrogen-bonds (Fig. 3f & Supplemen-
tary Fig. 1). In PKGIa, catalytic domain side chain atoms of D399,
K393, T400, F505, C519, P522 and E658 were participating in the
dense hydrophobic interactions, i.e. with F74, F81, R78, F84 and
A61. Donor-p-interactions between the sidechain atoms of H396,
F518 of the catalytic domain and F74 and F84 of the AI domain
were also observed in AI3 complex (Fig. 3f).
In all the three selected complexes, AI2 and AI3 showed the
binding of almost all the residues of pseudo-substrate motif with
the catalytic domain residues. A smaller number of RAQGISA inter-
actions were noted in the AI1 complex. From the docking interac-
tion analysis, it was observed that in the complex AI3, three
autophosphorylation sites T58, S65 and T85 of AI domain were
occupied by D657, E658 and P522 respectively, through polar
interactions (Supplementary Fig. 1). With the exception of the
AI3 complex, both complexes lack these interactions. Studies
reported the less rigid interactions of these autophosphorylation
sites with the catalytic domain. From the docking analysis, we
selected AI2 and AI3 for MD simulations.
3.3. Molecular dynamics simulations analysis
3.3.1. RMSD and Rog
The dynamics of the two best docked conformers (AI2 & AI3)
were compared through all atom simulation using AMBER14 tools.
To evaluate the conformational stability of our selected complexes,
root mean square deviation (RMSD), root mean square fluctuation
(RMSF) and radius of gyration (Rog) were investigated for all back-
bone atoms through CPPTRAJ.Fig. 4 (upper panel) shows 50 ns RMSD trajectories of our top
two ClusPro reported docked complexes of the AI domain with
the catalytic domain. From the RMSD graph shown in Fig. 5, we
observed that both AI domain-bound complexes are stable as com-
pared to their apo-forms. No radical fluctuations in the peaks of AI2
and AI3 complexes were observed as compared to the apo-form.
Selected complexes of AI and PKGI-a catalytic domain (denoted
as AI2 and AI3) showed an average RMSD of 2.25 Å and 2.4 Å
respectively (see Fig. 5). Whereas the apo system in which the AI
domain is absent, showed an average RMSD of 2.25 Å till 30 ns, a
sudden fluctuation to 4 Å was noticed at 35 ns which indicates a
freely fluctuating pocket which otherwise accommodates ligand
or pseudo-substrate motif in its inhibited state. After 35 ns, the
apo-form again attained stability. Both AI domain-bound com-
plexes showed a stable binding behaviour throughout the 50 ns
simulation time. Our analysis revealed that binding of the AI
domain to the catalytic domain confers stability to the docked sys-
tems by lowering its configurational space, possibly indicating the
engagement of critical secondary structural elements of the cat-
alytic pocket.
In addition to RMSD, the radius of gyration Rog was also inves-
tigated in the current study. Rog is an additional stability indicator
that indicates the mass-weighted RMS distance of a cluster of
atoms from their mean centre of mass; this provides a global
dimension of the protein’s mobility.
Rog analysis shown in Fig. 4 (lower panel) demonstrates that
both selected AI domain-bound conformers of catalytic domain
were found to be less variable throughout the simulation. There-
fore, the overall values of Rog for AI2 and AI3 were approximately
20.4 Å, which signify moderate fold movement among all systems
(Fig. 4). While the apo-form of the catalytic domain experiences a
Fig. 4. Root mean square deviation (RMSD) and radius of gyration (Rog) graphs
illustrating the stability of best-docked complexes of AI domain and the catalytic
domain of PKGIa (AI2: purple; AI3: green) in comparison to the apo- form of the
PKGIa catalytic domain (cyan). (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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cating the excitability of the ligand-free system. The results sug-
gest that the structural fold of the catalytic domain when bound
to the pseudo-substrate motif of the AI domain is actually con-
tributing to the compactness of the AI2 and AI3 complexes overFig. 5. Root mean square fluctuation (RMSF) analysis of the AI domain and catalytic dom
PKGIa catalytic domain (cyan). Secondary structure labelling of PKGIa catalytic domain (P
reader is referred to the web version of this article.)the course of the simulation. The Rog analysis results are in line
with the RMSD stability analysis.
3.3.2. RMSF
In order to estimate the conformational flexibility of PRKGIa-
catalytic domain upon binding the AI domain, RMSF was calculated
for each system under study by considering the overall magnitude
of fluctuation of each Ca-atom. Regions of the catalytic domain that
anchor the AI domain in the AI2 and AI3 systems showed less fluc-
tuation as compared to the apo-state. Within the catalytic pocket,
the AI domain establishes electrostatic interactions with the resi-
dues present at b1, L2, L3, a2, L4, a3, L5, b5, L7, b6, a4, a6, a7, L10,
L12, L13, a9 and L20 regions of catalytic domain. During simulation,
conformational changes in these important secondary structure
elements were monitored. RMSF analysis of the catalytic domain
revealed that in the apo-form b1, L2, L3, a2, L12, L13 and a9 showed
an average 1.8 Å RMSF respectively, which indicates highly fluctu-
ating regions (Fig. 5). Smaller amplitudes of displacements were
observed at the aforementioned binding regions as all these attain
stability after establishing interactions with the AI domain.
3.4. Hydrogen-Bond analysis
To focus more on the binding properties of the AI and catalytic
domains, we analysed the hydrogen-bond propensity which corre-
sponds to the interactions that occur persistently during the MD
simulations. The hydrogen-bonds formed between AI2 and AI3
complexes with occupancy greater than 20% are enlisted in Table 1
and Table 2 respectively.
In the PKGIa AI2 complex, the contributing residues of the cat-
alytic domain were located at the L2, b1, a2, a3,b6, a4, a6, L12, a8, , L20
making protein–protein interactions with the R60, A61, Q62, G63,
S65, A66, E67, Q69, Y71, R72, R78, Q79 and R82 of AI domain. In
PKGIa catalytic domain, the side chains of E658: L12, V368: b1,
G369, G370: loop2, H396: a2 were specifically interacting with
R60, A61, Q62, G63 and S65 residues of pseudo-substrate motif
(RAQGISA). Interaction of the conserved glycine-rich b-hairpin loop
residues i.e. G369, G370 and F371 with residues of the pseudo-
substrate motif in the inhibited form are also reported in cAMP
specific kinase (PKA). The pseudo-substrate motif not only sta-
bilises the ATP-binding lobe of the catalytic domain but also sta-
bilises the AGC kinase subdomain in the largest lobe by
establishing hydrogen- bonds of remarkable occupancy. In theain conformers of PKGIa (AI2: purple; AI3: green) in comparison to the apo form of
DB Id: 6BDL). (For interpretation of the references to colour in this figure legend, the
Table 1
Comparison of hydrogen-bond interactions between binding modes AI2 and AI3 representing the docked conformations of AI domain and catalytic domain of PKGIa.
Auto-inhibitory-Catalytic Domain Complex Acceptor Donor Percentage Occupancy Average Distance Average Angle
AI2 ASP_502@ O: loop12 ARG_78@N 92.57 2.77 154.43
GLY_370@O: loop2 GLN_62@NE2 74.70 2.84 157.04
ASP_399@H: a2 GLU_67@OE1 73.66 2.84 156.28
GLU_658@OE2: loop20 ARG_60@NH1 72.78 2.79 158.60
GLY_504@O: loop12 TYR_71@N 71.62 2.76 161.95
ASP_650@OD1: loop20 ARG_82@NH2 63.90 2.81 158.26
GLY_369@O: loop2 GLN_62@NE2 60.08 2.84 158.48
HIS_396@O: a2 GLY_63@N 53.90 2.91 153.62
VAL_368@O: b1 GLN_62@NE 50.08 2.81 157.06
GLU_488@OE1: loop8 GLN_79@NE2 43.33 2.80 161.99
ILE_406@O: a3 ARG_60@N 42.33 2.83 159.35
GLY_370@O: loop2 SER_65@H 39.78 2.90 141.29
GLU_445@OE1: a6 TYR_71@OH 36.57 2.69 164.71
GLU_488@OE1: loop8 ARG_72@NH1 37.65 2.78 163.07
GLU_402@OE1: a2 ARG_602@NH1 35.09 2.79 158.53
GLY_370@O: loop2 ALA_61@H 33.67 2.91 145.84
SER_651@O: loop20 ARG_78@NH2 32.51 2.82 150.08
ASP_657@OD2: loop20 ARG_60@NE 29.37 2.76 174.89
GLU_550@OE2: a8 ARG_72@NH2 28.50 2.80 152.19
THR_521@O: a7 GLN_69@NE2 27.63 2.87 160.04
GLU_445@OE2: a6 ARG_82_NH1 23.70 2.85 147.42
ASN_656_O: loop20 ARG_60_NH2 22.46 2.87 157.50
ASP_452_OD2: a4 GLN_62_N 21.44 2.74 168.39
AI3 THR_521@O: a7 ASP_76 @N 92.97 2.67 166.35
ASP_399@OD2: a2 GLN_62@NE2 73.66 2.84 156.28
THR_521@OG1: a7 VAL_49@N 62.10 2.91 150.68
VAL_368@O: b1 GLN_62@NE2 50.08 2.81 157.06
ARG_401@O: loop4 GLN_62@N 50.00 2.79 159.69
HIS_396@O: a2 GLY_63@N 47.30 2.62 153.62
GLU_444@OE1: b6 ARG_82@NH1 45.08 2.74 153.80
LEU_366@O: b1 ARG_82@N 36.93 2.82 148.53
ASP_655@O: loop20 ARG_60@NH2 36.59 2.78 161.38
ASP_657@O: loop20 ARG_60@NE 33.90 2.80 155.82
PHE_371@OXT: loop2 THR_52@OG1 33.46 2.85 142.76
GLU_439@O: b5 THR_52@N 32.09 2.89 154.16
PHE_518@O:loop13 GLN_69@NE2 32.37 2.79 155.21
ASP_657@O: loop20 ALA_61@H 30.02 2.89 163.45
GLU_445@OE1: b6 ARG_82@NH2 29.46 2.82 148.30
GLY_370@O: loop2 ALA_66@NH2 28.49 2.92 145.84
VAL_368@O: b2 ARG_78@NH1 28.50 2.86 146.46
GLU_444@OE2: b6 ARG_78@NE1 27.13 2.85 143.06
LYS_393@O: b3 GLN_62@N 31.76 2.85 162.62
GLU_488@OE1: a6 GLN_79@NE2 25.22 2.83 164.20
GLU_488@OE2: a6 LYS_83@N 25.62 2.73 160.13
GLY_372@O: b2 GLN_62@NE2 24.34 2.86 160.19
ASP_502@OD1: loop12 ARG_78@NH2 23.52 2.73 148.49
ASN_656@OD1: loop20 ARG_60@NH1 22.02 2.81 155.65
GLU_658@O: loop20 ARG_60@HE 22.55 2.80 156.96
GLN_402@OE1: a3 LYS_47@NZ 23.64 2.85 157.93
GLY_370@O: loop2 SER_65@OG 23.54 2.90 141.29
HIS_396@O: a2 SER_65@N 20.54 2.75 151.84
GLY_369@O:loop2 GLN_62@NE2 20.48 2.91 143.90
Table 2
Intradomain hydrogen-bond interactions in the apo-catalytic domain of PKGIa.
Catalytic Domain Acceptor Donor Percentage Occupancy Average Distance Average Angle
APO GLU_550@O: a8 TYR_524@OH: a7 91.89 2.72 163.73
PHE_371@O: L2 LYS_394@N: b4 0.6928 2.86 164.47
GLY_554@O: a8 ARG_451@NH1: a4 61.05 2.85 151.42
GLU_439@OE1: L7 ARG_423@NH1: L5 46.50 2.88 149.91
ASP_650@OD1: L20 ARG_451@N: a4 36.21 2.80 160.50
ASP_502@OD2: L12 ASN_489@N: a6 32.03 2.86 158.53
HIS_405@NE2: a3 LYS_507@NZ: b7 36.40 2.92 152.84
ASP_502@OD1: L12 TYR_482@N: L10 30.24 2.75 156.23
ASP_502@O: L12 LYS_390@N: b5 27.23 2.78 158.37
GLU_445@O: b6 VAL_368@N: b6 27.010 2.91 156.98
GLU_404@O: a3 LYS_507@N: b7 25.16 2.77 153.23
PHE_371@OXT: L2 LYS_393@N: b3 23.54 2.86 158.17
GLY_370@O: L2 LYS_393@NZ: b3 21.48 2.83 151.91
GLY_369@O: L2 HIS_396@N: a2 21.00 2.82 158.77
GLY_504@O: b10 HIS_405@N: a3 20.89 2.85 154.15
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(loop2) were observed while four residues S651, N656, D657 and
E658 of the AGC kinase subdomain show high-affinity binding with
the AI domain (Table 1). Ligand-interaction analysis using Ligplot+
and hotspot analysis of the co-crystal structure of PKGI-a (PDB Id:
6C0T) revealed that four residues, F371: L2 (glycine rich loop),
E439: L7, C441: L7 and D502: L12 are critical catalytic residues that
have a critical role in the activity of PKGIa. To understand the inhi-
bitory potential of the binding mode of the AI domain in AI2 con-
former, we noticed that D502:L12 forms a hydrogen-bond of 92.57%
bond occupancy with R78 of the autoinhibitory region while none
of the other critical catalytic residues were observed to be involved
in interdomain hydrogen-bonding. Residues adjacent to F371,
including V368, G369 and G370, keep the glycine-rich loop (loop2)
engaged in the interactions with residues of the pseudo-substrate
motif over 50 ns simulation time.
To select the best configuration of the AI domain docked inside
the catalytic domain, we analysed the hydrogen-bonding pattern
of the AI3 complex, shown in Table 1. Hydrogen-bond analysis
revealed that the AI domain binds through hydrogen-bonds of high
occupancy throughout the 50 ns simulations with approximately
twenty-four catalytic domain residues. Table 1 indicates the resi-
dues of the catalytic domain including L366, V368: b1, G369,
G370, F371: L2, G372: b2, K393: b3, H396, D399:a2, R401, Q402:
L4, E439: b5, E445: b6, E488: a6, D502: L12, F518: L13, T521: a8,
D655, N656, D657, E568: L20 appear to form hydrogen-bonds with
K47, V49, T53, R60, A61, Q62, G63, S65, A66, D76, R78, Q79, R82,
K83. These hydrogen-bond interactions involve binding of the
pseudo-substrate motif (RAQGISA) to the loop2, commonly known
as the glycine-rich loop, a2, L4, b3, and L20. These secondary struc-
ture regions cover the ATP-binding small lobe and the large lobe
of the kinase subdomain as well as the AGC kinase domain, which
is important for the function of the PKGIa catalytic domain. In
complex AI3, it was also observed that all the critical catalytic resi-
dues, i.e. F371: L2, D502: L12, E439: b5 except C441 are involved in
accommodating the AI domain within the catalytic cleft with max-
imum hydrogen-bond occupancy. Based on the hydrogen-bond
interaction analysis, the AI3 binding mode is considered to be
the best possible configuration of the AI domain through which
the pseudo-substrate motif blocks the activity of the PKGIa.
3.5. Motion mode analysis (PCA)
Following the hydrogen-bond analysis, essential dynamics
associated with the concentrated eigenvectors of AI2, AI3 and
apo form of PKGIa catalytic domain were extracted to explore
the configurational space more precisely. The first and second
eigenvectors (PC1&PC2) from the PCA analysis are presented in
Fig. 6. The lengths of the porcupine quills represent the strength
and degree of the motion while the heads of the arrows represent
the direction of the motion. Principal component analysis (PCA) of
AI3 showed potential movements within the small lobe and larger
lobe of the catalytic domain. In apo-system a1 showed significant
flexibility that might help the C-terminal catalytic domain in com-
ing closer to the AI domain located at the N-terminal in the inhib-
ited state (Fig. 6a). After AI domain binding, L4, which is present
between a3 and a4, moves slightly outward to accommodate the
AI domain. The AI domain helix moves inward to interact with resi-
dues located at L12 and L13, which are lying at the junction of the
small and large lobe of the catalytic domain and constitute the cen-
tral deep groove of the catalytic pocket. L12 connects b9 to b10 while
L13 is connecting a7 and b10. Interaction of L12 and L13 residues with
the autoinhibitory helix pulls a7, b9 and b10 of catalytic domain clo-
ser to the AI domain milieu. Furthermore, a6 and a9 also show a
tendency of inward movement towards loop13 and establish
intradomain interactions that add more to the compactness ofPKGIa catalytic domain. In comparison to the apo structure, there
are few contacts between the AI domain and a6 and a9 helices of
the catalytic domains of PKGIa that hold the pseudo-substrate
motif and stabilize the closed/ inactive conformation. In the apo-
structure, the opening of the catalytic pocket is a little wider com-
pared to AI3 because a9 helix in the apo-form is tilted away while
in the AI3 complex a9 helix tends to move inwards, which might
indicate the entrapping of the AI domain between the small and
large subdomains.
In the apo-state the restricted movement between the small
and large lobes might be a consequence of a significant number
of intradomain protein interactions. Specifically, the residues lying
on a3, a4, a6, a7 and b10 are actively participating in the intrado-
main interactions with the residues of neighbouring secondary
structures. Intradomain interactions in the apo system are shown
in Table 2. While these aforementioned interactions are replaced
by new interdomain protein–protein interactions in the AI-
catalytic complexes (AI2, AI3).
The loop region of the AI domain carrying RAQGISA shows high
flexibility and intrudes inside the catalytic pocket, establishing
interactions with G444 and E445 of b6 in the AI3 complex (Table 1).
These particular interdomain interactions may influence secondary
structure movements inside the binding pocket and help to bring
b5 and b6 closer by introducing hydrogen-bond interactions
between E439 (critical catalytic residue) and Thr52 of AI domain.
Unlike the AI3 complex, AI2 does not show significant
secondary-structure transition in the catalytic domain after bind-
ing the AI domain. In Fig. 3 the AI domain lies slightly away from
the binding pocket in AI2, while in AI3 it lies within the catalytic
pocket where its highly flexible loop region tends to move inside
the catalytic domain. The results from the hydrogen-bond interac-
tion analysis and PCA analysis imply that AI3 is a more plausible
binding mode that introduces convincing inter-domain interac-
tions and undergoes significant conformational changes that are
important to various aspects of the activity of the PKGIa in
humans.
3.6. Dimer modelling
Our predicted homo-dimeric homology model of inactive PKGIa
involves residues 103-671, which includes two consecutive cGMP
binding domains and the C-terminal catalytic domain. While the
cGMP-bound active-state homodimer is composed of 1-671 resi-
dues covering the N-terminal leucine-zipper domain, AI domain,
four cGMP-binding domains (CNB-A, CNB-B) and a C-terminal cat-
alytic domain.
Ramachandran analysis of the initial inactive model showed
83.2% of all residues in favoured while 93.7% of all residues were
found in allowed regions. While the refined inactive model showed
91.8% of all residues in favoured regions, 7.8% and 0.4% of all resi-
dues were in allowed regions and outlier regions respectively
demonstrating that the refined model is more stable than the ini-
tial one. In the active model, 93.2% of all residues are in favoured
region, and 98.5% of all residues are in allowed regions after refine-
ment. The RSMD difference of the final model with the crystal
structure of the individual domains of human PKGIa is <0.8 Å
RMSD. Orientations of all the adjacent domains in PKGIa inactive
state model given in Fig. 7a & b are in agreement with the orienta-
tions of neighbouring domains proposed in inactive conformer of
PKGIa by Kim et al., 2016.
Similarly, the best dimer model of the active chain of PKGIawas
selected and validated through its superposition with the crystal
structure of tandem CNB domains that are critical for active state
dimerization (PDB Id: 4Z07), which showed an RMSD difference
of 0.475 Å. The minimum RMSD score indicates that the full-
length active-state model of PKGIa retained all the dimer contacts
Fig. 6. The first two principal components (PC-1) and (PC-2) calculated for the apo-state of PKGIa catalytic domain (a, b) and the AI domain-bound complexes of PKGIa
catalytic domain AI2 (c, d) and AI3 (e, f). The catalytic domain is shown in green colour and the AI domain is in red colour. The direction and magnitude of secondary structure
movement is depicted in blue colour. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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the full-length active PKGIa is found consistent with the plausible
domain orientation given in study by Kim et al., 2015 (Fig. 8A & B).
In the inactive state model shown in Fig. 7b, the long central
helix that connects the two cGMP-binding domains in a single
chain keeps them away from each other while in the active state,
the central helix breaks and bends in the centre to bring cGMP
binding tandem domains closer to each other. In the inactive state
the cGMP binding domain A is coupled with the cGMP binding
domain B of the sister chain (Fig. 8A & B). However, in the active
model, cGMP domains of the two sister chains become uncoupled
from each other (Fig. 7A & B).
In the PCA analysis of apo system, the N-terminal helix of the
catalytic domain showed largescale movement (Fig. 6). Ligand
induced conformational changes are communicated from the reg-ulatory region of PKGIa to its catalytic region through this switch
/N-terminal a1 helix of catalytic domain. Previous studies reported
the role of this helix in bringing a large conformational change
from active sate to inactive state [12,33,59]. Movement of this
helix might help the catalytic domain to bend over and entrap AI
domain that is located at the N-terminal of PKGIa. Alongside,
structural changes in the long central helix bridging CNB-A and
CNB-B domains are also playing a key role in switching PKGIa in
two different functional states [60]. In an inactive state, the sister
chains in PKGIa homodimer are arranged antiparallel to each
other. Long central helix bridging CNB-A and CNB-B domains
extends due to the ligand uncoupling. A similar domain organiza-
tion of tandem CNB-A and CNB-B domains and structural features
of this central long helix were observed in the crystal structure of
the regulatory subunit of PKAIIb in Mus musculus (PDB Id: 4X6Q)
Fig. 7. Surface (A) and cartoon (B) representation of active-state model of full-
length human (PKGIa) in complex with four cGMP molecules. Leucine zipper
domains (LZ: grey), Auto-inhibitory domain (AI: red), cGMP binding domain A
(CNB-A: blue), cGMP binding domain B (CNB-B: cyan) and catalytic domain (green).
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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ken, this might allow the cGMP-binding domains to displace from
their positions. In the inactive state, it was observed that CNB-A
domain of the A chain is facing the CNB-B domain of the B-chain.
Both these domains might be involved in dimerization but in the
active state model, the CNB-A chain is facing the central helix of
the B chain that connects the tandem domains. The regions
between the tandem CNB domains of A and B chains and the cGMP
molecules are involved in the dimerization of the two chains. It has
been the reported that the rearrangement of the dimeric interac-
tion is due to cGMP binding at CNBs domains that causes slight
domain displacement in the active state [61,62]. Inter-domain
interaction pattern of the tandem CNB-A and CNB-B as well as
the local and global changes in their dynamics upon cGMP bindingFig. 8. Surface (A) and cartoon (B) representations of inactive-state model of full-length
(CNB-B: cyan) and catalytic domain (green). (For interpretation of the references to coloand cAMP binding in PKG and PKA, respectively are important for
the elongation and activation of these homologous enzymes
[63,64].
The adjustments of the CNB domains as a result of cGMP bind-
ing might bring a significant movement in the N-terminal helix of
the catalytic domain to dislodge it from the AI domain. A distinct
third state of PKGIb also exists due to partial agonism of cyclic ade-
nosine monophosphate (cAMP). cAMP induced dynamic changes in
switch helix influence the relative orientation of regulatory and
catalytic region of PKG [59].4. Discussion
In this study, we explore the domain-domain interactions of AI
and catalytic domains that govern the self-inhibitory mechanism
of PKGIa using computational biophysical and in silico structure
prediction methods. The inhibitory behaviour of AI and the cat-
alytic domain is investigated in order to understand the molecular
mechanism of autoinhibition of the PKGIa. In kinases, protein–pro-
tein interactions of two domains are often mediated by the pres-
ence of a regulatory motif that mimics the substrate and whose
particular recognition sites are present on the partner domain
[12]. Protein-protein interactions between specific binding part-
ners at distinct recognition sites help the proteins to fold, assemble
and evolve into complex molecular machines with specific func-
tions [16,65]. Careful positioning of AI pseudo-substrate motif is
critical for the proper functioning of the PKGIa.
To unravel the autoinhibitory mechanism of PKGIa, this study
aims at understanding the nature of interactions involved in the
inhibition of the catalytic activity. Although the nature of the resi-
dues in the pseudo-substrate motif of cyclic nucleotidyl protein
kinases has been widely studied, less has been done regarding
the structural aspects of the autoinhibition of the PKGIa. Protein
docking, comprehensive interdomain-interactions analysis and
MD simulation analysis provide evidence of the preferred con-
former of the AI domain in the inactive state. Experimental studies
have reported the role of catalytic residues (F371, E439, C441 and
D502) that are lying at the glycine rich loop L2, b5 and L12 in the
catalytic activity of the PKGIa [11,66]. It is also evident that
pseudo-substrate motif RAQGISA is stabilising the positions of
the residues of the glycine-rich loop and substrate-binding lobe
[33]. Our findings with respect to the occupancy of critical catalytichuman (PKGIa). cGMP binding domain A(CNB-A: purple), cGMP binding domain B
ur in this figure legend, the reader is referred to the web version of this article.)
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domain are consistent with the experimental studies [66,67]. The
presence of a helix in the AI domain that lies well inside the cat-
alytic grove and the pseudo-substrate-motif-containing loop that
snakes into the catalytic domain are also observed in the closely
related PKA [68].
Docking interaction analysis identified polar interactions of cat-
alytic residues i.e. D657, E658 and P522 with three of the four
autophosphorylation sites i.e. T58, S65 and T85 of the AI domain.
Among these residues, S65 has been reported to be significantly
involved in increasing autoinhibition and decreasing cGMP binding
affinity [10,13]. The region (611–658) present on the AGC kinase
region of the C-terminal lobe is the conserved substrate-binding
core of eukaryotic kinases [69]. In this study, three autophosphory-
lation sites of the AI domain are proposed to be engaged through
polar interactions with the residues of the catalytic domain in
the AI3 complex. Additionally, glutamate residues (observed in
the AI3 complex) within the catalytic pocket are also considered
as important residues that bind with the autoinhibitory pseudo-
substrate motif that might block the activation of the PKGIa and
retain it in the inhibited state. Several lines of evidence support
the binding of the experimentally-reported auto-phosphorylation
sites and pseudo-substrate motif of the AI domain through polar
and hydrogen-bond interactions with the critical secondary struc-
tures of the small and large lobe of the catalytic domain in our
selected complex [10,12,13,32,70].
It has been well established that human PKGIa exhibits differ-
ent conformations in its active and inactive forms. Studies suggest
that PKGIa experiences large conformational changes in order to
switch from an inactive globular form to the catalytically active
and elongated state. Large multiunit quaternary organization of
the PKGIa apo- and holo-enzymes has been predicted in the cur-
rent study by assembling all the available experimental and pre-
dicted structures. In the stable closed conformation, the catalytic
domain folds over the central connecting helix of the cGMP binding
domains (CNB-A & CNB-B) and the distance between a1 helix of the
catalytic domain and CNB-B decreases, probably inducing protein–
protein interactions between them. These changes may allow the
catalytic domain to come closer to the CNB-A domain and arrest
the AI domain more easily as this domain is located at the N-
terminal closer to CNB-A domain. In the closely related PKA, the
linker harbouring inhibitory sequence helps stabilizing the inactive
by disrupting its weak interactions with a-subdomain of the CNB-
A domain which results in enhanced regulatory region and cat-
alytic domain interface [64,71].
While in its active global structure, our results suggest that the
a1 helix of the catalytic domain has moved away from the CNB-B
domain, which might have pushed the catalytic domain away from
the CNB-A domain. Flexibility of the N-terminal a1 helix of cat-
alytic domain, as observed in the MD simulations of the apo-
form and the AI-catalytic domain complexes, might help the PKGIa
to switch between the compact ball-like folded inactive-state to an
elongated active PKGI-a form. Our data also indicate high flexibil-
ity in the a1 helix located the N-terminal of catalytic domain which
connects the catalytic domain with the regulatory region of the
PKGIa. A study by Huang et al. (2014) proposed large conforma-
tional changes in the N-terminal a1 helix of the catalytic domain
as well as in the central connecting helix of CNB domains (A and
B) shown in supplementary Fig. 2 helps in lodging and dislodging
of the regulatory region to/from the catalytic region [61 60,72].
Essential dynamics analysis highlighting the rigorous movement
of this helix also underlined the highly dynamic nature the a1
helix.
Past studies have reported a highly globular inactive state and a
dumbbell-extended active-state conformation of PKGIa [9,73] This
conformational change is due to the slight rearrangement of tan-dem cGMP-binding domains and their central connecting long a
helix conformation that further dictates the a1 helix of the catalytic
domain to arrest or withdraw the AI domain. In switching from an
open state to the closed state, role of dynamic linkers that are
bridging different domain including central helix connecting
CNB-A and CNB-B and N-terminal helix of the catalytic domain
has been discussed above but modelling the loop/linker that con-
nect the AI domain to the CNB-A domain was not successful in this
study. Structural information of this particular dynamics linker is
important in deciding the cis or trans- allosteric regulatory mecha-
nism in PKGIa. Recently a study reported the trans-inhibition
mechanism in PKGIb in which the regulatory region of one PKG
monomer binds the catalytic region of the other chain but we lack
the experimental information yet [74].
Consistent with the already proposed observation, we conclude
that the conformational dynamics is being driven by the protein–
protein interactions between the PKGIa catalytic domain and the
AI domain. The open and closed configurations of human PKGIa
and structural details about the auto-inhibition mechanism,
revealed in the present study, are although computationally-
based but they provide strong basis for the proposed inner com-
plex regulatory mechanism of human PKGIa in the cGMP sig-
nalling pathway.
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